Gabriel de Erausquin

Dr. Gabriel de Erausquin is the Zachry Foundation Distinguished Professor of Neurology and Research Professor at the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases. His work bridges clinical neurology, neuroimaging, and translational research, with a focus on Alzheimer's disease, neurodegenerative disorders, and the neuropsychiatric consequences of systemic infections like SARS-CoV-2. He leads multicenter studies using advanced neuroimaging techniques (e.g., 7T MRI) to map brain structural and functional changes. His research also addresses psychiatric comorbidities in dementia, genetic networks influencing personality, and culturally adapted community health strategies for aging populations.

Dr. de Erausquin's team investigates novel therapeutic approaches, including antiretroviral therapy repurposing (ART-AD) and rapamycin trials for Alzheimer's. His studies on post-COVID cognitive impairment highlight the role of Type I interferon signaling pathways and olfactory dysfunction. He collaborates globally through consortia like the Alzheimer’s Association International Cohort Study, emphasizing diverse populations including Hispanic and Andean communities.

• Key awards: Zachry Foundation Distinguished Professorship
• Major projects: Alzheimer’s Association Global Consortium on SARS-CoV-2 sequelae, South Texas Alzheimer’s Disease Research Center
• Clinical focus: Integrating genomic data with neuroimaging and neuropsychiatric outcomes

His work extends to mental health education in resource-limited settings, including training programs for rural psychiatry and community health workers. Dr. de Erausquin’s interdisciplinary approach addresses both molecular mechanisms (e.g., gene expression networks) and societal impacts of neurodegenerative diseases.